ctrl K

Price Alert

Arrowhead Pharmaceuticals... (ARWR)

NASDAQ: ARWR · Real-Time Price · USD

20.29

0.43 (2.17%)

At close: Aug 20, 2025, 1:22 PM

Arrowhead Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	102.69M	110.89M	108M	184.43M
Short-Term Investments	578.28M	292.74M	268.39M	183.35M
Long-Term Investments	n/a	n/a	105.87M	245.59M
Other Long-Term Assets	4.48M	210K	29.12M	272K
Receivables	n/a	n/a	1.41M	10.26M
Inventory	n/a	n/a	-21.61M	4.36M
Other Current Assets	4.97M	7.08M	41.82M	-2.17M
Total Current Assets	695.47M	419.52M	405.3M	384.6M
Property-Plant & Equipment	431.29M	335.56M	168.59M	66.02M
Goodwill & Intangibles	8.56M	10.26M	11.96M	13.66M
Total Long-Term Assets	444.33M	346.03M	315.54M	325.55M
Total Assets	1.14B	765.55M	691.94M	710.15M
Account Payables	11.39M	35.87M	2.87M	9.46M
Deferred Revenue	n/a	866K	74.1M	111.06M
Short-Term Debt	n/a	n/a	2.78M	2.25M
Other Current Liabilities	432K	435K	-2.78M	-2.25M
Total Current Liabilities	103.17M	105.46M	138.85M	146.54M
Long-Term Debt	393.18M	268.33M	n/a	n/a
Other Long-Term Liabilities	341.36M	n/a	n/a	131.5M
Total Long-Term Liabilities	845.57M	372.93M	134.75M	154.79M
Total Liabilities	948.74M	478.39M	273.6M	301.33M
Total Debt	510.55M	383.5M	81.58M	25.55M
Common Stock	217K	200K	198K	197K
Retained Earnings	-1.63B	-1.03B	-820.75M	-644.69M
Comprehensive Income	4.75M	-3.22M	-136K	-69K
Shareholders Equity	185.44M	271.34M	398.52M	408.82M
Total Investments	578.28M	292.74M	374.26M	428.95M